IN8bio, Inc. (INAB) Misses Q2 EPS by 2c

IN8bio, Inc. (NASDAQ: INAB) reported Q2 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on IN8bio, Inc. (INAB) click here.

You May Also Be Interested In

• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• BT Brands posts Q2 profit, cuts costs as restaurant sales dip
• Jefferies on Pony AI Inc (PONY): 'overseas expansion is increasingly shifting toward JDM'